Tag Archives: Eli Lilly
By Pharm Exec | Published: March 26, 2014
An interactive training program designed “to help patient advocates better influence decisions related to access to new medicines” was launched today by Eli Lilly.
By William Looney | Published: December 4, 2013
The pursuit of excellence in biopharmaceutical innovation in Russia has never had a sponsor—until now. Prix Galien International, a global network of Nobel laureates in medicines, established its 18th country beachhead in Moscow earlier this year, culminating in a historic first: an October 24 awards dinner to recognize the best in new drug research as […]
By Marylyn Donahue | Published: November 20, 2013
The radical shift currently taking place in pharma marketing is all about partnering with patients rather than talking at them. In other words, pharma and patients are becoming friends who can help their “partners” educate, design a diet plan, increase disease awareness, and take you to the doctor…well, not quite yet.
By Clark Herman | Published: October 30, 2013
At last week’s 4th annual Prix Galien Forum hosted by the Alexandria Center in New York, industry leaders gathered to discuss trends and developments that shape the intersection between science and policy. The centerpiece of the day was a panel on US health reform – focused on rollout of the Affordable Care Act — featuring […]
By admin | Published: September 30, 2013
Doing deals with storytellers could be as important for pharma as collaborating with research scientists, writes Peter Houston. Leading advertising trade publication Ad Week ran an interesting feature on the ‘New Face of Big Pharma Marketing’ this week. The piece outlines the changes that Obamacare combined with public distrust of pharma is forcing on marketers, noting […]